Geode Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.53M | Sell |
304,597
-6,735
| -2% | -$55.9K | ﹤0.01% | 3063 |
|
2025
Q1 | $1.9M | Buy |
311,332
+8,242
| +3% | +$50.2K | ﹤0.01% | 3054 |
|
2024
Q4 | $1.92M | Buy |
303,090
+3,792
| +1% | +$24K | ﹤0.01% | 3144 |
|
2024
Q3 | $1.5M | Sell |
299,298
-2,280
| -0.8% | -$11.4K | ﹤0.01% | 3213 |
|
2024
Q2 | $1.84M | Buy |
301,578
+81,824
| +37% | +$500K | ﹤0.01% | 3145 |
|
2024
Q1 | $2.44M | Buy |
219,754
+1,164
| +0.5% | +$12.9K | ﹤0.01% | 3041 |
|
2023
Q4 | $2.45M | Buy |
218,590
+12,391
| +6% | +$139K | ﹤0.01% | 3026 |
|
2023
Q3 | $1.55M | Buy |
206,199
+9,322
| +5% | +$70K | ﹤0.01% | 3166 |
|
2023
Q2 | $1.74M | Buy |
196,877
+177,370
| +909% | +$1.57M | ﹤0.01% | 3156 |
|
2023
Q1 | $162K | Hold |
19,507
| – | – | ﹤0.01% | 4145 |
|
2022
Q4 | $187K | Hold |
19,507
| – | – | ﹤0.01% | 4139 |
|
2022
Q3 | $158K | Hold |
19,507
| – | – | ﹤0.01% | 4340 |
|
2022
Q2 | $110K | Hold |
19,507
| – | – | ﹤0.01% | 4553 |
|
2022
Q1 | $109K | Sell |
19,507
-112
| -0.6% | -$626 | ﹤0.01% | 4628 |
|
2021
Q4 | $86K | Sell |
19,619
-290
| -1% | -$1.27K | ﹤0.01% | 4767 |
|
2021
Q3 | $187K | Buy |
19,909
+1,983
| +11% | +$18.6K | ﹤0.01% | 4477 |
|
2021
Q2 | $130K | Sell |
17,926
-151,430
| -89% | -$1.1M | ﹤0.01% | 4488 |
|
2021
Q1 | $1.05M | Buy |
169,356
+1,513
| +0.9% | +$9.39K | ﹤0.01% | 3538 |
|
2020
Q4 | $1.25M | Buy |
167,843
+12,056
| +8% | +$89.8K | ﹤0.01% | 3294 |
|
2020
Q3 | $944K | Buy |
155,787
+5,587
| +4% | +$33.9K | ﹤0.01% | 3236 |
|
2020
Q2 | $1.25M | Buy |
+150,200
| New | +$1.25M | ﹤0.01% | 3073 |
|
2019
Q2 | – | Sell |
-46,059
| Closed | -$223K | – | 4223 |
|
2019
Q1 | $223K | Buy |
46,059
+6,570
| +17% | +$31.8K | ﹤0.01% | 3704 |
|
2018
Q4 | $251K | Buy |
39,489
+5,441
| +16% | +$34.6K | ﹤0.01% | 3608 |
|
2018
Q3 | $279K | Buy |
34,048
+4,799
| +16% | +$39.3K | ﹤0.01% | 3648 |
|
2018
Q2 | $305K | Buy |
+29,249
| New | +$305K | ﹤0.01% | 3594 |
|